Statement MD&A Financial Statement Revise 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unable to reach
Statement MD&A Financial Statement Revise 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an
Statement MD&A Financial Statement Revise 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an
opinion with an emphasis of matters 2019 Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion
opinion with an emphasis of matters 2019 Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion
Limited serves as the bondholder representative for PPH206A. The e-meeting’s agenda contains subject matters for consideration as follows: Agenda item 1: Consideration for approval of an
representative office in the Kingdom shall obtain an approval from the Office. The representative under the first paragraph shall undertake only those businesses specified in the approval. The provisions of
representative office in the Kingdom shall obtain an approval from the Office. The representative under the first paragraph shall undertake only those businesses specified in the approval. The provisions of
” means a securities company licensed to undertake securities business in the category of private fund management; “Marketing Representative of Private Funds” means a person appointed by a private fund
” means a securities company licensed to undertake securities business in the category of private fund management; “Marketing Representative of Private Funds” means a person appointed by a private fund